~~<i id='38F143918F'><strike id='38F143918F'><tt id='38F143918F'><pre id='38F143918F'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：explore 2025-09-29 15:14:57 Page View：7

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Group behind ProMed defends move to subscription
Next article： What does generative AI mean for health care? We asked experts

leisure time

ChatGPT in medicine: STAT answers readers' burning questions

MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

Group behind ProMed defends move to subscription

ProMEDmapScreengrabviaProMEDTheorganizationthatrunsProMed,anearlywarningsystemondiseaseoutbreaks,def

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

H.R. 3 is the wrong path to lower drug costs

Fromleft,Rep.RichardNeal(D-Mass.)speaksasRep.FrankPallone(D-N.J.)andHouseSpeakerNancyPelosi(D-Calif.

WSS

hotspot

hotspot

comprehensive

leisure time

H.R. 3 is the wrong path to lower drug costs